Zika virus seroprevalence, French Polynesia, 2014–2015

Emerging Infectious Diseases

Volumn 23, Issue 4, 2017, Pages 669-672

  Aubry, Maite ^a   Teissier, Anita ^a   Huart, Michael ^b,c   Merceron, Sébastien ^d   Vanhomwegen, Jessica ^e   Roche, Claudine ^a   Vial, Anne Laure ^f,g   Teururai, Sylvianne ^a   Sicard, Sébastien ^b,c   Paulous, Sylvie ^e   Desprès, Philippe ^h   Manuguerra, Jean Claude ^e   Mallet, Henri Pierre ^g   Musso, Didier ^a   Deparis, Xavier ^b,c   Cao Lormeau, Van Mai ^a  

^a Institut Louis Malarde   (France)

^b Centre d'épidémiologie et de santé publique des armées   (France)

^c CNRS   (France)

^d Centre Hospitalier de la Polynésie Française   (France)

^e INSTITUT PASTEUR   (France)

^f Départementale de la Cohésion Sociale et de la Protection des Populations   (France)

^g Institut de la Statistique de la Polynésie Française   (France)

^h UNIVERSITÉ DE LA RÉUNION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; RECOMBINANT ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DENGUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FRENCH POLYNESIA; HUMAN; IMMUNOASSAY; LOT QUALITY ASSURANCE SAMPLING; SEROPREVALENCE; ZIKA FEVER; BLOOD; EPIDEMIC; FEMALE; MALE; MIDDLE AGED; POLYNESIA; PRESCHOOL CHILD; SEROEPIDEMIOLOGY; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYNESIA; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT; ZIKA VIRUS INFECTION;

EID: 85015760101     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2304.161549     Document Type: Article

References (15)

1. Musso D, Gubler DJ. Zika Virus. Clin Microbiol Rev. 2016;29:487–524. http://dx.doi.org/10.1128/CMR.00072-15
2. Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387:1531–9. http://dx.doi.org/10.1016/S0140-6736(16)00562-6
3. Cauchemez S, Besnard M, Bompard P, Dub T, Guillemette-Artur P, Eyrolle-Guignot D, et al. Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study. Lancet. 2016;387:2125–32. http://dx.doi.org/10.1016/S0140-6736(16)00651-6
4. Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med. 2009;360:2536–43. http://dx.doi.org/10.1056/NEJMoa0805715
5. Cao-Lormeau VM, Roche C, Teissier A, Robin E, Berry A-L, Mallet H-P, et al. Zika virus, French Polynesia, South Pacific, 2013. Emerg Infect Dis. 2014;20:1085–6. http://dx.doi.org/10.3201/eid2011.141380
6. Musso D, Nilles EJ, Cao-Lormeau VM. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect. 2014;20:O595–6. http://dx.doi.org/10.1111/1469-0691.12707
7. Mallet HP, Vial AL, Musso D. Bilan de l’épidémie à virus Zika survenue en Polynésie française entre octobre 2013 et mars 2014. De la description de l’épidémie aux connaissances acquises après l’évènement. Bulletin épidémiologique hebdomadaire. 2016;20–21:367–73.
8. Aubry M, Finke J, Teissier A, Roche C, Broult J, Paulous S, et al. Seroprevalence of arboviruses among blood donors in French Polynesia, 2011-2013. Int J Infect Dis. 2015;41:11–2. http://dx.doi.org/10.1016/j.ijid.2015.10.005
9. Spiegel A, Moulia-Pelat J, Daumerie D, Merlin M, Baudon D. Le sondage en grappe type OMS: méthodes pratiques en épidémiologie descriptive. Med Afr Noire. 1989;36:740–5.
10. Musso D, Nhan T, Robin E, Roche C, Bierlaire D, Zisou K, et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill. 2014;19:2pii=0761.
11. Chungue E, Marché G, Plichart R, Boutin JP, Roux J. Comparison of immunoglobulin G enzyme-linked immunosorbent assay (IgG-ELISA) and haemagglutination inhibition (HI) test for the detection of dengue antibodies. Prevalence of dengue IgG-ELISA antibodies in Tahiti. Trans R Soc Trop Med Hyg. 1989;83:708–11. http://dx.doi.org/10.1016/0035-9203(89)90404-5
12. Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G, Duangchinda T, et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol. 2016;17:1102–8. http://dx.doi.org/10.1038/ni.3515
13. Priyamvada L, Quicke KM, Hudson WH, Onlamoon N, Sewatanon J, Edupuganti S, et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A. 2016;113:7852–7. http://dx.doi.org/10.1073/pnas.1607931113
14. Kucharski AJ, Funk S, Eggo RM, Mallet H-P, Edmunds WJ, Nilles EJ. Transmission dynamics of Zika virus in island populations: a modelling analysis of the 2013–14 French Polynesia outbreak. PLoS Negl Trop Dis. 2016;10:e0004726. http://dx.doi.org/10.1371/journal.pntd.0004726
15. Johansson MA, Hombach J, Cummings DA. Models of the impact of dengue vaccines: a review of current research and potential approaches. Vaccine. 2011;29:5860–8. http://dx.doi.org/10.1016/j.vaccine.2011.06.042